These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 29197503)

  • 1. Serum metabolic profiling of type 2 diabetes mellitus in Chinese adults using an untargeted GC/TOFMS.
    Wang H; Zhang H; Yao L; Cui L; Zhang L; Gao B; Liu W; Wu D; Chen M; Li X; Ji A; Li Y
    Clin Chim Acta; 2018 Feb; 477():39-47. PubMed ID: 29197503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of metabolic biomarkers in patients with type 2 diabetic coronary heart diseases based on metabolomic approach.
    Liu X; Gao J; Chen J; Wang Z; Shi Q; Man H; Guo S; Wang Y; Li Z; Wang W
    Sci Rep; 2016 Jul; 6():30785. PubMed ID: 27470195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma metabolomics identified novel metabolites associated with risk of type 2 diabetes in two prospective cohorts of Chinese adults.
    Qiu G; Zheng Y; Wang H; Sun J; Ma H; Xiao Y; Li Y; Yuan Y; Yang H; Li X; Min X; Zhang C; Xu C; Jiang Y; Zhang X; He M; Yang M; Hu Z; Tang H; Shen H; Hu FB; Pan A; Wu T
    Int J Epidemiol; 2016 Oct; 45(5):1507-1516. PubMed ID: 27694567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fasting serum lipid and dehydroepiandrosterone sulfate as important metabolites for detecting isolated postchallenge diabetes: serum metabolomics via ultra-high-performance LC-MS.
    Liu L; Wang M; Yang X; Bi M; Na L; Niu Y; Li Y; Sun C
    Clin Chem; 2013 Sep; 59(9):1338-48. PubMed ID: 23620415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum metabolite signatures of type 2 diabetes mellitus complications.
    Wu T; Xie G; Ni Y; Liu T; Yang M; Wei H; Jia W; Ji G
    J Proteome Res; 2015 Jan; 14(1):447-56. PubMed ID: 25245142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small intestine proteomics coupled with serum metabolomics reveal disruption of amino acid metabolism in Chinese hamsters with type 2 diabetes mellitus.
    Wang C; Yu J; Zhang R; Wang W; Shi Z; Liu Y; Song G; Wang H; Han N; Huang L; An Y; Tian S; Chen Z
    J Proteomics; 2020 Jul; 223():103823. PubMed ID: 32428569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum and urine metabolomics reveal potential biomarkers of T2DM patients with nephropathy.
    Shao M; Lu H; Yang M; Liu Y; Yin P; Li G; Wang Y; Chen L; Chen Q; Zhao C; Lu Q; Wu T; Ji G
    Ann Transl Med; 2020 Mar; 8(5):199. PubMed ID: 32309346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Untargeted serum metabolomics reveals Fu-Zhu-Jiang-Tang tablet and its optimal combination improve an impaired glucose and lipid metabolism in type II diabetic rats.
    Tao Y; Chen X; Cai H; Li W; Cai B; Chai C; Di L; Shi L; Hu L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jan; 1040():222-232. PubMed ID: 27866845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phospholipidomic identification of potential plasma biomarkers associated with type 2 diabetes mellitus and diabetic nephropathy.
    Zhu C; Liang QL; Hu P; Wang YM; Luo GA
    Talanta; 2011 Sep; 85(4):1711-20. PubMed ID: 21872008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Free fatty acid metabolic profile and biomarkers of isolated post-challenge diabetes and type 2 diabetes mellitus based on GC-MS and multivariate statistical analysis.
    Liu L; Li Y; Guan C; Li K; Wang C; Feng R; Sun C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Oct; 878(28):2817-25. PubMed ID: 20846914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic signatures and risk of type 2 diabetes in a Chinese population: an untargeted metabolomics study using both LC-MS and GC-MS.
    Lu Y; Wang Y; Ong CN; Subramaniam T; Choi HW; Yuan JM; Koh WP; Pan A
    Diabetologia; 2016 Nov; 59(11):2349-2359. PubMed ID: 27514531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of metabolite profiles as biomarkers for the pharmacological effects of thiazolidinediones in Type 2 diabetes mellitus patients and healthy volunteers.
    van Doorn M; Vogels J; Tas A; van Hoogdalem EJ; Burggraaf J; Cohen A; van der Greef J
    Br J Clin Pharmacol; 2007 May; 63(5):562-74. PubMed ID: 17488363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic signatures and potential biomarkers of sarcopenia in suburb-dwelling older Chinese: based on untargeted GC-MS and LC-MS.
    Han P; Yuan C; Chen X; Hu Y; Hu X; Xu Z; Guo Q
    Skelet Muscle; 2024 Mar; 14(1):4. PubMed ID: 38454497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinctive Metabolomics Patterns Associated With Insulin Resistance and Type 2 Diabetes Mellitus.
    Gu X; Al Dubayee M; Alshahrani A; Masood A; Benabdelkamel H; Zahra M; Li L; Abdel Rahman AM; Aljada A
    Front Mol Biosci; 2020; 7():609806. PubMed ID: 33381523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of GC/MS-based metabonomic profiling in studying the therapeutic effects of Huangbai-Zhimu herb-pair (HZ) extract on streptozotocin-induced type 2 diabetes in mice.
    Song L; Liu H; Wang Y; Wang Y; Liu J; Zhou Z; Chu H; Zhuang P; Zhang Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Aug; 997():96-104. PubMed ID: 26094210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum metabonomics of NAFLD plus T2DM based on liquid chromatography-mass spectrometry.
    Chen Y; Li C; Liu L; Guo F; Li S; Huang L; Sun C; Feng R
    Clin Biochem; 2016 Sep; 49(13-14):962-6. PubMed ID: 27211699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolomics Study of Roux-en-Y Gastric Bypass Surgery (RYGB) to Treat Type 2 Diabetes Patients Based on Ultraperformance Liquid Chromatography-Mass Spectrometry.
    Luo P; Yu H; Zhao X; Bao Y; Hong CS; Zhang P; Tu Y; Yin P; Gao P; Wei L; Zhuang Z; Jia W; Xu G
    J Proteome Res; 2016 Apr; 15(4):1288-99. PubMed ID: 26889720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabonomic variations in the drug-treated type 2 diabetes mellitus patients and healthy volunteers.
    Bao Y; Zhao T; Wang X; Qiu Y; Su M; Jia W; Jia W
    J Proteome Res; 2009 Apr; 8(4):1623-30. PubMed ID: 19714868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fasting serum α‑hydroxybutyrate and pyroglutamic acid as important metabolites for detecting isolated post-challenge diabetes based on organic acid profiles.
    Chou J; Liu R; Yu J; Liu X; Zhao X; Li Y; Liu L; Sun C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Nov; 1100-1101():6-16. PubMed ID: 30267980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated biomarker profiling of the metabolome associated with type 2 diabetes mellitus among Tibetan in China.
    Meng J; Huang F; Shi J; Zhang C; Feng L; Wang S; Li H; Guo Y; Hu X; Li X; He W; Cheng J; Wu Y
    Diabetol Metab Syndr; 2023 Jul; 15(1):146. PubMed ID: 37393287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.